ESR1 and breast cancer: Moreover, CAPE seems synergistic with tamoxifen on MCF-7 breast cancer cells (Motawi et al., 2016), and has induced radiosensitivity on MDA-MB-231 (estrogen receptor negative) and T47D (estrogen receptor positive) breast cancer cell lines (Khoram et al., 2016).